Literature DB >> 27779558

MICROBIOLOGIC SPECTRUM AND VISUAL OUTCOMES OF ACUTE-ONSET ENDOPHTHALMITIS UNDERGOING THERAPEUTIC PARS PLANA VITRECTOMY.

Jayanth Sridhar1, Yoshihiro Yonekawa, Ajay E Kuriyan, Anthony Joseph, Benjamin J Thomas, Michelle C Liang, Nadim Rayess, Nidhi Relhan, Jeremy D Wolfe, Chirag P Shah, Andre J Witkin, Harry W Flynn, Sunir J Garg.   

Abstract

PURPOSE: To report the clinical presentation, microbiologic spectrum, and visual outcomes associated with acute-onset infectious endophthalmitis undergoing therapeutic pars plana vitrectomy.
METHODS: Multicenter interventional retrospective noncomparative consecutive case series. Billing records were reviewed to identify all charts for patients undergoing pars plana vitrectomy within 14 days of diagnosis of acute-onset infectious endophthalmitis over a 4-year period at 5 large tertiary referral retina practices. Statistical analysis was performed to assess for factors associated with visual outcomes.
RESULTS: Seventy patients were identified. The most common clinical setting was postcataract surgery (n = 20). Only 3 patients (4.3%) presented with 20/400 or better visual acuity (VA). Although most of the patients initially underwent vitreous tap and intravitreal antibiotic injection (n = 47, 67.1%), all patients eventually underwent pars plana vitrectomy within 14 days of presentation with 68.5% (48/70) of patients undergoing pars plana vitrectomy within 48 hours of presentation. Positive intraocular cultures were obtained in 56 patients (80%). The most common identified organism was Streptococcus sp (n = 19). Visual acuity at last follow-up was 20/400 or better in 19 patients (27.1%). Three patients underwent evisceration or enucleation (4.3%). Last recorded postoperative VA (mean LogMAR 1.99 ± 0.94, Snellen VA equivalent finger count) improved from presenting VA (mean LogMAR 2.37 ± 0.38, Snellen VA hand motions) (P ≤ 0.001). There was no statistically significant correlation between the underlying etiology or the timing of surgery with this VA outcome.
CONCLUSION: Although less than one-third of patients achieved 20/400 or better VA, this VA often improved significantly from presenting VA.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27779558      PMCID: PMC5400738          DOI: 10.1097/IAE.0000000000001358

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  21 in total

1.  Visual acuity measurements.

Authors:  Jack T Holladay
Journal:  J Cataract Refract Surg       Date:  2004-02       Impact factor: 3.351

2.  Legacy of the endophthalmitis vitrectomy study.

Authors:  Harry W Flynn; Ingrid U Scott
Journal:  Arch Ophthalmol       Date:  2008-04

3.  Early intravitreal treatment of endogenous bacterial endophthalmitis.

Authors:  Yoshihiro Yonekawa; R V Paul Chan; Ashok K Reddy; Cristiana G Pieroni; Thomas C Lee; Sangwoo Lee
Journal:  Clin Exp Ophthalmol       Date:  2011-04-21       Impact factor: 4.207

4.  The results of pars plana vitrectomy and silicone oil tamponade for endophthalmitis after intravitreal injections.

Authors:  Eylem Yaman Pinarci; Nilufer Yesilirmak; Sezin Akca Bayar; Selcuk Sizmaz; Imren Akkoyun; Gursel Yilmaz
Journal:  Int Ophthalmol       Date:  2013-01-01       Impact factor: 2.031

5.  Endoscopic Vitrectomy for Severe Posttraumatic Endophthamitis with Visualization Constraints.

Authors:  Lijun Shen; Bin Zheng; Zhenquan Zhao; Yan Chen
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2010-03-09

6.  The ischemic optic neuropathy decompression trial (IONDT): design and methods.

Authors: 
Journal:  Control Clin Trials       Date:  1998-06

7.  Vision-related quality of life in people with central retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire.

Authors:  Vincent A Deramo; Terry A Cox; Arjumand B Syed; Paul P Lee; Sharon Fekrat
Journal:  Arch Ophthalmol       Date:  2003-09

8.  Comparative outcomes of pars plana vitrectomy in acute postoperative endophthalmitis with 25-gauge and 20-gauge techniques.

Authors:  Tugrul Altan; Ziya Kapran; Ilker Eser; Nur Acar; Yaprak Banu Unver; Serap Yurttaser
Journal:  Jpn J Ophthalmol       Date:  2009-10-22       Impact factor: 2.447

9.  Vitreous cultures in suspected endophthalmitis. Biopsy or vitrectomy?

Authors:  S P Donahue; R P Kowalski; B H Jewart; T R Friberg
Journal:  Ophthalmology       Date:  1993-04       Impact factor: 12.079

10.  Early vitrectomy in the treatment of post-operative purulent endophthalmitis.

Authors:  L Laatikainen; A Tarkkanen
Journal:  Acta Ophthalmol (Copenh)       Date:  1987-08
View more
  2 in total

1.  The clinical outcomes of keratoplasty in irreversible corneal decompensation secondary to Axenfeld-Rieger syndrome.

Authors:  Ting Yu; Jing Hong; Ge-Ge Xiao; Rong-Mei Peng
Journal:  Int Ophthalmol       Date:  2022-05-20       Impact factor: 2.029

Review 2.  Endophthalmitis: Changes in Presentation, Management and the Role of Early Vitrectomy.

Authors:  Emily H Shao; William B Yates; I-Van Ho; Andrew A Chang; Matthew P Simunovic
Journal:  Ophthalmol Ther       Date:  2021-10-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.